Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy.
Antinori
A
A
Lazzaro Spallanzani National Institute for Infectious Diseases, IRCCS, Rome, Italy.
Liuzzi
G
G
Cingolani
A
A
Bertoli
A
A
Di Giambenedetto
S
S
Trotta
M P
MP
Rizzo
M G
MG
Girardi
E
E
De Luca
A
A
Perno
C F
CF
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D024882:Drug Resistance, Viral / Q000235:genetics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000821:virology*; D016333:HIV Protease / Q000235:genetics*; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics / Q000276:immunology; D006801:Humans; D008297:Male; D017354:Point Mutation; D012367:RNA, Viral / Q000097:blood; D017211:Treatment Failure; D019562:Viral Load
D012367:RNA, Viral; D054303:HIV Reverse Transcriptase; D016333:HIV Protease